# Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)

> **NCT07353762** · — · NOT_YET_RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 10960 (estimated)

## Conditions studied

- Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07353762
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2035-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 10960 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07353762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07353762, "Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07353762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*